Synergistic Restoration of the Atopic Skin Microbiome: A Pharmacological Review of Lactobacillus and Saccharomyces Postbiotics Combined with Perilla frutescens Exosomal Innovations

Background: Atopic dermatitis (AD) is a chronic inflammatory disease characterized by profound dysbiosis, Staphylococcus Aureus colonization, and a compromised epidermal barrier. Current therapies often face safety and compliance limitations, necessitating proactive, steroid-sparing ecological restorations. Methods: This pharmacological review evaluates a synergistic framework combining Lactobacillus and Saccharomyces postbiotic lysates with innovative Perilla frutescens plant-derived exosomes, analyzing their molecular impact on skin homeostasis. Results: Our analysis demonstrates that Lactobacillus enhances innate immunity, while Saccharomyces ferments support the microbial ecosystem, showing an 87% increase in elastin secretion and a 41% increase in collagen type I synthesis, essential for barrier repair. Furthermore, Perilla frutescens exosomes modulate the JAK-STAT pathway, reducing Interleukin-6 (IL-6) by 40% and downregulating CYP1A1 expression by up to 49%, thereby mitigating oxidative stress and pruritus. Conclusions: By integrating these components into a "Triple-Action Therapy"—focusing on immunomodulation, structural restoration, and precision anti-inflammatory signaling—this review provides a comprehensive evidence-based roadmap for next-generation dermo-cosmetic interventions in atopic skin management.